Dr. Lukas J. Farbiak is a biomedical engineering innovator and academic leader whose work in genetic medicine is transforming how diseases are treated at the molecular level. As an Assistant Professor at UT Southwestern and Co-Founder of Signify Bio, Inc., he merges deep scientific expertise with translational impact—developing advanced lipid nanoparticle platforms and signal peptide technologies that enable precise, tissue-specific delivery of therapeutic nucleic acids. With over 15 peer-reviewed publications and 20+ patent filings, Dr. Farbiak stands at the cutting edge of non-viral drug delivery and personalized therapeutics, bringing a rare blend of academic rigor, entrepreneurial vision, and collaborative leadership to every endeavor.

Dr. Gilles Besin is a visionary scientific executive whose career spans over 20 years at the forefront of RNA therapeutics and immunology. As Chief Scientific Officer at Orbital Therapeutics, he is redefining the landscape of next-generation RNA medicine through groundbreaking work in mRNA and circular RNA platforms. From leading vaccine development programs to spearheading major biotech acquisitions, Dr. Besin blends deep scientific expertise with strategic insight, positioning him as a driving force in translating cutting-edge research into real-world therapeutic solutions.